US Edition
Published • loading... • Updated
Why these treatments for one of the deadliest cancers are stirring such hope
The drug’s median survival was 13.2 months versus 6.7 months with chemotherapy, and the Food and Drug Administration could approve it this year.
Summary by The Frederick News-Post
4 Articles
4 Articles
The Frederick News-Post+2 Reposted by 2 other sources
Why these treatments for one of the deadliest cancers are stirring such hope
SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly lethal forms of the disease.
·Georgia, United States
Read Full Article
On the cancer front, the progress of treatments to prolong life, improve comfort and avoid too invasive side effects has been impressive in recent years. But some tumors remain formidable, especially those affecting the pancreas. Indeed, today, 5 years after diagnosis, only 13% of patients are still there and immunotherapy has failed to improve this figure. Also read > Pancreatic cancer: what are the signs that should alert? That is why the simu…
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
